Friedberg Ezra M
SEC Form 4 insider trading activity
Friedberg Ezra M has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 7, 2026.
On the most recent filing, Friedberg Ezra M is listed as Director at Pelthos Therapeutics Inc. Inside the rolling window, Friedberg Ezra M reported no open-market purchases and 4 open-market sales totaling $314K in PTHS. The largest disclosed transaction in the window is a sale of 10,000 PTHS shares on Nov 25, 2025, worth $280K.
Companies traded
Other insiders at PTHS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$314K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Friedberg Ezra M made?
Friedberg Ezra M has filed 6 SEC Form 4 filings (14 transaction rows) across 1 company since 2025.
Which companies does Friedberg Ezra M trade?
Friedberg Ezra M has filed SEC Form 4 disclosures for 1 company, including PTHS.
When was Friedberg Ezra M's most recent SEC Form 4 filing?
Friedberg Ezra M's most recent SEC Form 4 filing on Tracefour is dated Jul 7, 2026.
What is Friedberg Ezra M's total buy and sell value in the current window?
Inside the rolling retention window, Friedberg Ezra M bought $0 and sold $314K based on SEC Form 4 filings.
What was Friedberg Ezra M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 PTHS shares on 2025-11-25, worth $280K, per SEC Form 4 filings.